Convene Pharma Private Limited
About Convene Pharma Private Limited
Data last updated:
Convene Pharma Private Limited is a private limited company based in Shimla, Himachal Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24100HP2017PTC006708. Its GSTIN is 02AAHCC1564D1Z8 (Himachal Pradesh).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹21.45 Lakh. It is led by directors Poonam Devi and Sushil Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Theog House Lakkar Bazar Lakkar Bazar, Shimla, Himachal Pradesh, India – 171001.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.85 Cr, a growth of 87% compared to the previous year. For the same year it recorded a net profit of ₹23.11 Lakh (net margin 8.1%) and EBITDA of ₹25.33 Lakh (EBITDA margin 8.9%). Revenue has grown at a compounded annual rate (CAGR) of 68% over three years and 33% over five years.
As per MCA filings, the company has open charges of ₹42 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressTheog House Lakkar Bazar Lakkar Bazar, Shimla, Himachal Pradesh, India – 171001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Convene Pharma Private Limited
The main business activity of Convene Pharma is trade. In detail, this covers wholesale trading and retail trading. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Convene Pharma Private Limited FY 2025 filings available
Convene Pharma Private Limited reported revenue of ₹2.85 Cr (up 87% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Convene Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 87% growth in the latest year. EBITDA rose 234% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Convene Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹25.33 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹23.11 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Convene Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Convene Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Convene Pharma Private Limited
Convene Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Moral Nutraceuticals Private Limited | ₹2.86 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Ahmedabad, Gujarat, India |
| Florence Life Care Private Limited | ₹2.86 Cr (FY 2024) | •••• | •••• | 43.0% | •••• | Agra, Uttar Pradesh, India |
| Blupin Healthcare Private Limited | ₹2.86 Cr (FY 2025) | •••• | •••• | 190.0% | •••• | Rawatsar, Rajasthan, India |
| Elipse Labs Marketing Private Limited | ₹2.86 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Thrissur, Kerala, India |
| Roots Life Sciences (India) Private Limited | ₹2.85 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Hyderabad, Telangana, India |
| Convene Pharma Private Limited this company | ₹2.85 Cr (FY 2024) | •••• | •••• | 87.0% | •••• | Shimla, Himachal Pradesh, India |
| Alankar Private Limited | ₹2.85 Cr (FY 2022) | •••• | •••• | 22.0% | •••• | Mumbai, Maharashtra, India |
| Tradeniger Impex Private Limited | ₹2.84 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Mumbai, Maharashtra, India |
| Infochem Pharma Private Limited | ₹2.84 Cr (FY 2024) | •••• | •••• | 39.0% | •••• | Kankerbagh, Bihar, India |
| Mission Cure Pharma Private Limited | ₹2.84 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Ahmedabad, Gujarat, India |
| Axegis (India) Private Limited | ₹2.84 Cr (FY 2024) | •••• | •••• | 32.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Convene Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Convene Pharma Private Limited
Convene Pharma Private Limited is audited by NAVNEET & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NAVNEET & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Convene Pharma Private Limited
Convene Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poonam Devi | Director | 21 Aug 2017 | 9 Years 1 Months | Current |
| Sushil Kumar | Director | 21 Aug 2017 | 9 Years 1 Months | Current |
Ownership and Shareholding of Convene Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Convene Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2022 | Hdfc Bank Limited | ₹42 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Convene Pharma Private Limited
Employment history and EPFO contributions of people linked to Convene Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Convene Pharma Private Limited
Convene Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Poonam Devi was appointed as Director on 21 Aug 2017.
Credit Ratings, Litigation & Regulatory Alerts for Convene Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Convene Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Convene Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Convene Pharma Private Limited
Convene Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAHCC1564D1Z8 | Himachal Pradesh | Active | 04 Oct 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Convene Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Convene Pharma Private Limited
Convene Pharma is an active private limited company based in Shimla, Himachal Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 August 2017 (9+ years old) and is registered under CIN U24100HP2017PTC006708.
Convene Pharma reported revenue of ₹2.85 Cr for FY 2024 (up 87% YoY).
Convene Pharma has 2 current directors:
- Poonam Devi - Director
- Sushil Kumar - Director
Convene Pharma reported a net profit of ₹23.11 Lakh (net margin 8.1%) and EBITDA of ₹25.33 Lakh (EBITDA margin 8.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Convene Pharma is 68% over three years and 33% over five years. In the latest year (FY 2024) revenue rose 87%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Convene Pharma is 02AAHCC1564D1Z8, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Convene Pharma is U24100HP2017PTC006708. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Convene Pharma was incorporated on 21 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Convene Pharma by revenue are Moral Nutraceuticals Private Limited, Florence Life Care Private Limited, Blupin Healthcare Private Limited, Elipse Labs Marketing Private Limited, Roots Life Sciences (India) Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Poonam Devi was appointed as Director on 21 Aug 2017. Sushil Kumar was appointed as Director on 21 Aug 2017.
The registered office of Convene Pharma is at Theog House Lakkar Bazar Lakkar Bazar, Shimla, Himachal Pradesh, India – 171001.